GSWM
GILD icon

Golden State Wealth Management’s Gilead Sciences GILD Stock Holding History

Golden State Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
1,277
+62
+5% +$8.17K 0.01% 453
2026
Q1 		$169K Buy
1,215
+19
+2% +$2.66K 0.02% 405
2025
Q4 		$147K Sell
1,196
-39
-3% -$4.74K 0.02% 441
2025
Q3 		$137K Buy
1,235
+1
+0.1% +$114 0.02% 440
2025
Q2 		$137K Buy
1,234
+371
+43% +$39.5K 0.02% 418
2025
Q1 		$96.8K Buy
863
+109
+14% +$11.2K 0.01% 451
2024
Q4 		$69.7K Buy
+754
New +$67.9K 0.01% 509
2021
Q2 		– Sell
-3,462
Closed -$223K – 310
2021
Q1 		$223K Sell
3,462
-882
-20% -$56.9K 0.07% 185
2020
Q4 		$253K Buy
+4,344
New +$262K 0.07% 203
2020
Q2 		– Sell
-603
Closed -$46.2K – 467
2020
Q1 		$45K Buy
+603
New +$41.7K 0.02% 376
2019
Q4 		– Sell
-374
Closed -$24K – 392
2019
Q3 		$24K Sell
374
-272
-42% -$17.8K 0.01% 583
2019
Q2 		$43K Sell
646
-150
-19% -$9.87K 0.01% 487
2019
Q1 		$52K Buy
+796
New +$52.9K 0.02% 430

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Golden State Wealth Management's GILD Position: Q2 2026 in Review

Golden State Wealth Management increased its Gilead Sciences (GILD) stake by 5.1% in Q2 2026, buying an estimated $8.17K and bringing the position to 1,277 shares worth $161K. The position accounts for 0.01% of the portfolio, ranked #453.

Golden State Wealth Management first reported a position in GILD in Q1 2019 and has held it in 13 quarters since. The position peaked at $253K in Q4 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Golden State Wealth Management held 1,277 shares of Gilead Sciences worth $161K as of Q2 2026.
  • Golden State Wealth Management bought 62 Gilead Sciences shares in Q2 2026, an estimated $8.17K.
  • Gilead Sciences made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #453 holding.
  • Golden State Wealth Management first reported a position in Gilead Sciences in Q1 2019 and has held it in 13 quarters since.
  • Golden State Wealth Management's Gilead Sciences position peaked at $253K in Q4 2020.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.